Exosens (CHIX:EXENSP) Total Stockholders Equity: €445.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:EXENSP Exosens SA CHIX:EXENSP
46 GF Score
Price €58.73
! 7 Warning Signs
View Full Analysis

What is Exosens Total Stockholders Equity?

Exosens CHIX:EXENSP 46 Total Stockholders Equity is €445.6 Mil as of Dec. 2025. GuruFocus rates CHIX:EXENSP with a GF Score™ of 46/100. The stock has 7 warning signs investors should review.

Exosens's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €445.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Exosens's Book Value per Share for the quarter that ended in Dec. 2025 was €8.79. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Exosens's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.04.

Exosens  (CHIX:EXENSp) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Exosens's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(445.6-0)/50.689
=8.79

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Exosens's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3 + 13.6) / 445.6
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exosens Total Stockholders Equity Related Terms

Exosens Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Exosens's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exosens Total Stockholders Equity Chart

Exosens Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 172.11 183.05 204.07 412.60 445.60

Exosens Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 204.07 381.98 412.60 429.50 445.60
CHIX:EXENSP
46GF Score
Exosens SA CHIX:EXENSP
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €445.6 Mil mean?
Exosens (CHIX:EXENSP) has a Total Stockholders Equity of €445.6 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Exosens and its competitors.
Is Exosens' Total Stockholders Equity too high?
Exosens' current Total Stockholders Equity is €445.6 Mil. Overall, Exosens has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' Total Stockholders Equity compare to VRT and BE?
Exosens' Total Stockholders Equity of €445.6 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for an Industrial Products company?
A good Total Stockholders Equity depends on the Industrial Products industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Exosens and its competitors. Exosens's current Total Stockholders Equity is €445.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (CHIX:EXENSP) has a current Total Stockholders Equity of €445.6 Mil. The current Total Stockholders Equity is €445.6 Mil. Exosens' overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Exosens (CHIX:EXENSP), the current Total Stockholders Equity is €445.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exosens Business Description

Address 18 Avenue de Pythagore, Domaine de Pelus, Axis Business Park Bat 5E, Merignac, FRA, 33700
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
46GF Score

Get the complete analysis for CHIX:EXENSP

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€58.73
Price